| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1028-4559(08)60073-X |
| P698 | PubMed publication ID | 18603499 |
| P50 | author | Chien-Nan Lee | Q37375458 |
| P2093 | author name string | Po-Jen Cheng | |
| Chih-Ping Chen | |||
| T'sang-T'ang Hsieh | |||
| Jenn-Jeih Hsu | |||
| Sheng-Wen Shaw | |||
| Ching-Hua Hsiao | |||
| P2860 | cites work | Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study | Q56764725 |
| UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation | Q57523616 | ||
| Anomalous fetal venous return associated with major chromosomopathies in the late first trimester of pregnancy | Q58970645 | ||
| Free beta-hCG as first-trimester marker for fetal trisomy | Q67537231 | ||
| Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome | Q70056433 | ||
| An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities | Q72729435 | ||
| Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome | Q72730932 | ||
| Aneuploidy in twin gestations: when is maternal age advanced? | Q73028290 | ||
| Maternal serum screening for down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an asian population. a prospective study | Q73557276 | ||
| Integrated screening for Down's syndrome based on tests performed during the first and second trimesters | Q78109767 | ||
| First-trimester screening for trisomies 21 and 18 | Q79133560 | ||
| In response to 'Certificate of competence in performing specific procedures or tests in screening practice' | Q79873877 | ||
| Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome | Q80182867 | ||
| Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan | Q81502921 | ||
| Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation | Q81702543 | ||
| Monozygotic twins discordant for monosomy 21 detected by first-trimester nuchal translucency screening | Q82433707 | ||
| Ectopia cordis in a fetus with trisomy 18 | Q82882256 | ||
| ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 | ||
| Down syndrome phenotypes: the consequences of chromosomal imbalance | Q35344729 | ||
| Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 | ||
| First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome | Q35822399 | ||
| Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy | Q35822995 | ||
| Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble. | Q36260861 | ||
| Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies | Q37125977 | ||
| Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters | Q39216527 | ||
| Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004. | Q40245899 | ||
| Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation | Q41885240 | ||
| Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies | Q44125568 | ||
| First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. | Q45291831 | ||
| Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome | Q46169856 | ||
| Practical strategies in contingent sequential screening for Down syndrome | Q46623158 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| SURUSS in perspective | Q47339084 | ||
| The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening. | Q47859470 | ||
| Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement | Q48541378 | ||
| Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level | Q50148910 | ||
| Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. | Q51140638 | ||
| Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group. | Q52304753 | ||
| P433 | issue | 2 | |
| P921 | main subject | Down syndrome | Q47715 |
| P304 | page(s) | 157-162 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Taiwanese Journal of Obstetrics & Gynecology | Q26853808 |
| P1476 | title | First- and second-trimester Down syndrome screening: current strategies and clinical guidelines | |
| P478 | volume | 47 |
| Q41542227 | Combined detection of α-fetoprotein and free β-human chorionic gonadotropin in screening for trisomy 21 and management of cases in the moderate risk value range |
| Q33849119 | Comparison of nuchal translucency measurements obtained using Volume NT(TM) and two- and three-dimensional ultrasound |
| Q34164343 | Down syndrome screening methods in Iranian pregnant women |
| Q43966671 | Effect of maternal hepatitis B carrier status on first-trimester markers of Down syndrome |
| Q83153147 | First- and Second-trimester Down Syndrome Screening: Current Strategies and Clinical Guidelines |
| Q42874803 | Maternal Homocysteine Level and Markers Used in First-Trimester Screening for Fetal Down Syndrome |
| Q50111068 | Prenatal diagnostic rates and postnatal outcomes of fetal orofacial clefts in a Taiwanese population |
| Q37739767 | Proficiency testing of maternal serum prenatal screening in second trimester in China, 2015. |
| Q43064398 | Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study |
Search more.